HYUNDAI BIOLAND Co.,Ltd. Logo

HYUNDAI BIOLAND Co.,Ltd.

Manufactures biomaterials for cosmetics, health supplements, and regenerative medicine.

052260 | KO

Overview

Corporate Details

ISIN(s):
KR7052260007
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명2로 22 SK 바이오랜드 오송공장, 청주시

Description

HYUNDAI BIOLAND Co., Ltd. is a comprehensive healthcare company specializing in the development and manufacturing of biomaterials from natural resources. The company's core business operates in three main sectors: cosmetic raw materials, health supplements (nutraceuticals), and biomedical materials for regenerative medicine. Leveraging expertise in collagen and hyaluronic acid manufacturing techniques, it provides high-tech bio-solutions for health and beauty. Its product portfolio includes active ingredients for the personal care industry, functional food materials, and medical devices such as resorbable membranes for dental and periodontal tissue regeneration. The company focuses on researching and supplying advanced biomaterials to a global market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-27 00:00
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 10.8 KB
2025-02-18 00:00
주주총회소집결의
Korean 23.5 KB
2025-02-18 00:00
주주총회소집공고
Korean 875.7 KB
2025-02-18 00:00
의결권대리행사권유참고서류
Korean 846.2 KB
2025-02-14 00:00
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.1 KB
2025-02-04 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 13.1 KB
2025-02-04 00:00
현금ㆍ현물배당결정
Korean 8.3 KB
2024-12-26 00:00
유상증자결정(종속회사의주요경영사항)
Korean 20.5 KB
2024-12-26 00:00
타법인주식및출자증권취득결정
Korean 25.9 KB
2024-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2024-12-13 00:00
기업설명회(IR)개최
Korean 6.7 KB
2024-12-02 00:00
기업설명회(IR)개최
Korean 6.8 KB
2024-11-29 00:00
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 10.2 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.2 MB
2024-11-12 00:00
기업설명회(IR)개최
Korean 6.7 KB

Automate Your Workflow. Get a real-time feed of all HYUNDAI BIOLAND Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HYUNDAI BIOLAND Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HYUNDAI BIOLAND Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.